Replies to post #30681 on Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

PotAto... potahto.. $350 million of accumulated losses with nothing to put on ones investment plate. FACT.

My intent was... TPIV 200 is not dead.
I, for one, consider that good news. There was no mention of prior c/ trials on the 3rd qtr filing.

Was it you who inferred that TPIV 100, 110, 200, and polystart were essentially " dead?"

I'm pleased that BC TPIV200 continues and AML and Pancreatic trials go forward with hopeful results..

This month. A close friend died from PC.
My S.in L. has AML so thus is why I remain so hopeful for success.